K. Hashine

发表

Radical retropubic prostatectomy: time trends, morbidity and mortality in Japan

T. Matsuda, O. Ogawa, S. Egawa, 2000, Prostate cancer and prostatic diseases.

Radiation pneumonitis caused by a migrated brachytherapy seed lodged in the lung.

M. Kataoka, Y. Sumiyoshi, N. Miura, 2008, Japanese journal of clinical oncology.

Ramucirumab plus docetaxel versus placebo plus docetaxel in patients with locally advanced or metastatic urothelial carcinoma after platinum-based therapy (RANGE): a randomised, double-blind, phase 3 trial

S. Culine, J. Hainsworth, R. Huddart, 2017, The Lancet.

The preliminary results of docetaxel-prednisolone combination therapy for the Japanese patients with hormone-refractory prostate cancer.

Y. Sumiyoshi, N. Miura, K. Hashine, 2007, Hinyokika kiyo. Acta urologica Japonica.

Should inclusion criteria for active surveillance for low-risk prostate cancer be more stringent? From an interim analysis of PRIAS-JAPAN

S. Egawa, H. Sasaki, N. Shinohara, 2015, World Journal of Urology.

Patient‐reported outcomes following neoadjuvant endocrine therapy, external beam radiation, and adjuvant continuous/intermittent endocrine therapy for locally advanced prostate cancer: A randomized phase III trial

Y. Ohashi, A. Yokomizo, S. Naito, 2021, Cancer medicine.

Oncological outcomes for patients with locally advanced prostate cancer treated with neoadjuvant endocrine and external-beam radiation therapy followed by adjuvant continuous/intermittent endocrine therapy in an open-label, randomized, phase 3 trial.

Y. Ohashi, A. Yokomizo, S. Naito, 2020, Cancer.

Tertiary Gleason pattern 5 and oncological outcomes after radical prostatectomy.

A. Shirato, K. Hashine, N. Teramoto, 2011, Japanese journal of clinical oncology.

Phase I/II study of S-1 in combination with sorafenib for metastatic renal cell carcinoma.

H. Akaza, Y. Tomita, M. Fujisawa, 2015, Annals of oncology : official journal of the European Society for Medical Oncology.

Final results of a phase II study of S-1 in patients with cytokine-refractory metastatic renal cell carcinoma.

H. Akaza, Y. Tomita, M. Fujisawa, 2014, Japanese journal of clinical oncology.

Role of bone scan index in the prognosis and effects of therapy on prostate cancer with bone metastasis: Study design and rationale for the multicenter Prostatic Cancer Registry of Standard Hormonal and Chemotherapy Using Bone Scan Index (PROSTAT‐BSI) study

K. Harada, K. Nakajima, H. Shiina, 2018, International journal of urology : official journal of the Japanese Urological Association.

Association Study of a Functional Variant on ABCG2 Gene with Sunitinib-Induced Severe Adverse Drug Reaction

K. Matsuda, T. Mushiroda, M. Kubo, 2016, PloS one.

Salvage Radiotherapy Versus Hormone Therapy for Prostate-specific Antigen Failure After Radical Prostatectomy: A Randomised, Multicentre, Open-label, Phase 3 Trial (JCOG0401)†.

K. Nihei, T. Habuchi, S. Egawa, 2019, European urology.

Efficacy and safety of abiraterone acetate plus prednisone in Japanese patients with newly diagnosed, metastatic hormone-naive prostate cancer: final subgroup analysis of LATITUDE, a randomized, double-blind, placebo-controlled, phase 3 study

K. Fizazi, N. Tran, N. Matsubara, 2018, Japanese journal of clinical oncology.

Influence of hospital surgical volume of radical prostatectomy on quality of perioperative care

T. Matsuda, S. Naito, Y. Arai, 2013, International Journal of Clinical Oncology.

Relationship of Positive Resection Margin, Cancer Location and Learning Curve after Laparoscopic Radical Prostatectomy

N. Yamashita, K. Hashine, N. Teramoto, 2017 .

M. Roobol, S. Egawa, H. Sasaki, 2020, World Journal of Urology.

Patient-reported outcomes after open radical prostatectomy, laparoscopic radical prostatectomy and permanent prostate brachytherapy.

K. Hashine, R. Tomida, Toshio Kakuda, 2019, Japanese journal of clinical oncology.

The impact of complications after initial prostate biopsy on repeat protocol biopsy acceptance rate. Results from the Prostate Cancer Research International: Active Surveillance JAPAN study

H. Kume, T. Matsuda, S. Egawa, 2020, International Journal of Clinical Oncology.

An open-label, phase 1 study of androgen receptor antagonist, apalutamide in Japanese patients with metastatic castration-resistant prostate cancer

H. Uemura, K. Hashine, K. Imanaka, 2019, International Journal of Clinical Oncology.

K. Hashine, I. Ninomiya, T. Nakashima, 2014, Japanese journal of clinical oncology.

Bladder preservation therapy conducted by intra-arterial chemotherapy and radiotherapy for muscle invasive bladder cancer.

M. Kataoka, Y. Sumiyoshi, N. Miura, 2009, Japanese journal of clinical oncology.

A randomized phase III trial of personalized peptide vaccination for castration-resistant prostate cancer progressing after docetaxel

M. Fujisawa, S. Egawa, S. Naito, 2020, Oncology reports.

Personalized peptide vaccination for castration-resistant prostate cancer progressing after docetaxel: A randomized, double-blind, placebo-controlled, phase III trial

M. Fujisawa, S. Egawa, S. Naito, 2020 .

Oral estramustine phosphate and oral etoposide for the treatment of hormone‐refractory prostate cancer

T. Karashima, Y. Sumiyoshi, K. Hashine, 2000, International journal of urology : official journal of the Japanese Urological Association.

Efficacy of Androgen Receptor-targeted Drugs After Prostate Cancer Recurrence With Bone Metastases: PROSTAT-BSI Sub-analysis

K. Harada, H. Yaegashi, H. Shiina, 2022, AntiCancer Research.

Efficacy of New Therapies for Relapse After Docetaxel Treatment of Bone Metastatic Castration-resistant Prostate Cancer in Clinical Practice

H. Shiina, H. Enokida, H. Matsuyama, 2022, AntiCancer Research.

Deferred radical prostatectomy in patients who initially elected for active surveillance: a multi-institutional, prospective, observational cohort of the PRIAS-JAPAN study

S. Egawa, H. Sasaki, A. Yokomizo, 2021, International Journal of Clinical Oncology.

Characteristic distribution of maculopapular rash caused by gemcitabine‐based chemotherapy

M. Tohyama, K. Hashine, A. Asagi, 2020, The Journal of dermatology.

Results of second transurethral resection for high-grade T1 bladder cancer

K. Hashine, N. Teramoto, I. Ninomiya, 2016, Urology annals.

Predictive factors for the effectiveness of novel androgen receptor axis‐targeted agents in patients with metastatic prostate cancer

K. Harada, H. Shiina, M. Oyama, 2022, International journal of urology : official journal of the Japanese Urological Association.

Predictor of response to salvage radiotherapy in patients with PSA recurrence after radical prostatectomy: the usefulness of PSA doubling time.

Y. Sumiyoshi, K. Hashine, K. Numata, 2005, Japanese journal of clinical oncology.

Murill, in Cancer Patients in Remission

S. Kyo, S. Ohno, Y. Sumiyoshi, 2014 .

Phase I Clinical Study of the Dietary Supplement, Agaricus blazei Murill, in Cancer Patients in Remission

S. Kyo, M. Inoue, S. Ohno, 2011, Evidence-based complementary and alternative medicine : eCAM.

[Intermittent intra-arterial chemotherapy for the treatment of patients with bladder cancer or prostate cancer using implantable injection pump].

K. Kasahara, K. Yokota, Y. Sumiyoshi, 1996, Nihon Hinyokika Gakkai zasshi. The japanese journal of urology.

Quality of life improvements among cancer patients in remission following the consumption of Agaricus blazei Murill mushroom extract.

S. Kyo, M. Inoue, S. Ohno, 2013, Complementary therapies in medicine.

Prognosis of patients with prostate cancer and bone metastasis from the Japanese Prostatic Cancer Registry of Standard Hormonal and Chemotherapy Using Bone Scan Index cohort study

K. Harada, K. Nakajima, H. Shiina, 2021, International journal of urology : official journal of the Japanese Urological Association.

Docetaxel-prednisolone combination therapy for Japanese patients with hormone-refractory prostate cancer: a single institution experience.

Y. Sumiyoshi, N. Miura, A. Shirato, 2010, Japanese journal of clinical oncology.

A Phase 2 Trial of Abiraterone Acetate in Japanese Men with Metastatic Castration-resistant Prostate Cancer and without Prior Chemotherapy (JPN-201 Study)

H. Akaza, H. Uemura, H. Uemura, 2014, Japanese journal of clinical oncology.

Dietary administration of mushroom mycelium extracts in patients with early stage prostate cancers managed expectantly: a phase II study.

N. Shinohara, Y. Kakehi, K. Yoshimura, 2010, Japanese journal of clinical oncology.

Changes in perioperative management of radical prostatectomy using clinical pathways according to a standardized care plan: A multi‐institutional study

T. Matsuda, S. Naito, Y. Arai, 2013, International journal of urology : official journal of the Japanese Urological Association.

Effect of genetic polymorphisms on outcomes following nivolumab for advanced renal cell carcinoma in the SNiP-RCC trial

M. Oya, M. Fujisawa, M. Shiota, 2023, Cancer Immunology, Immunotherapy.

[A morphological study of renal adenoma and latent renal cell carcinoma in autopsy cases].

S. Kagawa, Y. Sumiyoshi, K. Hashine, 1996, Nihon Hinyokika Gakkai zasshi. The japanese journal of urology.

Phase II clinical trial of sorafenib plus interferon-alpha treatment for patients with metastatic renal cell carcinoma in Japan

T. Fujioka, K. Tatsugami, S. Naito, 2015, BMC Cancer.

Kinetics differences between PSA bounce and biochemical failure in patients treated with 125I prostate brachytherapy.

H. Kanzaki, M. Kataoka, Hiromitsu Kanzaki, 2015, Japanese journal of clinical oncology.

Metastatic urachal adenocarcinoma successfully treated with surgery and chemotherapy

N. Tanji, M. Yokoyama, N. Miura, 2014, International Cancer Conference Journal.

Radical retropubic prostatectomy: time trends, morbidity and mortality in Japan

T. Matsuda, O. Ogawa, S. Egawa, 1999, Prostate Cancer and Prostatic Diseases.

Impact of carcinoma in situ on the outcome of intravesical Bacillus Calmette-Guérin therapy for non-muscle-invasive bladder cancer: a comparative analysis of large real-world data

H. Nishiyama, H. Miyake, C. Ohyama, 2022, International Journal of Clinical Oncology.

M. Kataoka, Y. Sumiyoshi, N. Miura, 2009, Japanese journal of clinical oncology.

Phase I trial of sorafenib in combination with interferon-alpha in Japanese patients with unresectable or metastatic renal cell carcinoma

Y. Hamamoto, H. Fujii, K. Fukino, 2009, Investigational new drugs.

A prospective longitudinal study comparing a radical retropubic prostatectomy and permanent prostate brachytherapy regarding the health-related quality of life for localized prostate cancer.

M. Kataoka, Y. Sumiyoshi, N. Miura, 2008, Japanese journal of clinical oncology.

Sequential immune-targeted surgical therapy resulted in disease-free survival in a case with advanced renal cell carcinoma

T. Saika, K. Nishimura, T. Fukumoto, 2021, BMC Urology.

Preliminary Results of Bladder Preservation by Concurrent lntraarterial Chemotherapy and Radiotherapy for Muscle‐Invasive Bladder Cancer

T. Karashima, K. Kasahara, Y. Sumiyoshi, 1998, International journal of urology : official journal of the Japanese Urological Association.

[Primary urothelial carcinoma of the prostate: a case of spread along ducts and into seminal vesicles].

Y. Sumiyoshi, N. Miura, A. Shirato, 2008, Nihon Hinyokika Gakkai zasshi. The japanese journal of urology.

Correlation between cancer location and oncological outcome after radical prostatectomy

N. Yamashita, K. Hashine, N. Teramoto, 2012, International journal of urology : official journal of the Japanese Urological Association.

[Prognostic factors for muscle-invasive bladder cancer treated with a combination of intra-arterial chemotherapy and low-dose radiotherapy].

K. Yokota, Y. Sumiyoshi, K. Hashine, 1994, Nihon Hinyokika Gakkai zasshi. The japanese journal of urology.

Significance of the timing of ureteral ligation on prognosis during radical nephroureterectomy for upper urinary tract urothelial cancer

H. Nishiyama, K. Kuroiwa, T. Habuchi, 2020, International journal of urology : official journal of the Japanese Urological Association.

Prospective longitudinal outcomes of quality of life after laparoscopic radical prostatectomy compared with retropubic radical prostatectomy

K. Hashine, I. Ninomiya, Shunsuke Iuchi, 2018, Health and Quality of Life Outcomes.

Chemoradiotherapy for Small-Cell Prostate Carcinoma: A Case Report

H. Kanzaki, Y. Hamamoto, K. Hashine, 2023, Cureus.

Radical prostatectomy trends between 2010 and 2020 in Ehime, Japan, identified using data from the Medical Investigation Cancer Network (MICAN) study

T. Saika, N. Miura, A. Shirato, 2023, International journal of urology : official journal of the Japanese Urological Association.

M. Kataoka, Y. Sumiyoshi, N. Miura, 2008, International journal of urology : official journal of the Japanese Urological Association.

Long-term outcomes of 60 Gy conventional radiotherapy combined with androgen deprivation for localized or locally advanced prostate cancer.

M. Kataoka, Y. Sumiyoshi, K. Hashine, 2005, Japanese journal of clinical oncology.

Y. Sumiyoshi, K. Hashine, T. Koizumi, 2005, International Journal of Clinical Oncology.

[Utility of prostate specific antigen doubling time in repeat biopsy for prostate cancer].

Y. Sumiyoshi, K. Hashine, K. Numata, 2006, Nihon Hinyokika Gakkai zasshi. The japanese journal of urology.

M. Kataoka, N. Yamashita, K. Hashine, 2011, International journal of urology : official journal of the Japanese Urological Association.

The efficacy of neoadjuvant androgen deprivation therapy as a prostate volume reduction before brachytherapy for clinically localized prostate cancer.

H. Kumon, T. Saika, S. Ebara, 2007, Acta medica Okayama.

Prolonged treatment with three-weekly docetaxel plus daily prednisolone for metastatic castration-resistant prostate cancer: a multicenter, phase II, open-label, non-comparative, extension study in Japan

T. Miki, H. Akaza, O. Ogawa, 2013, International Journal of Clinical Oncology.

Y. Sumiyoshi, K. Hashine, K. Azuma, 2005, Nihon Hinyokika Gakkai zasshi. The japanese journal of urology.

Patient-reported outcomes after robot-assisted radical prostatectomy and institutional learning curve for functional outcomes

K. Hashine, Y. Sawada, R. Minato, 2022, Urology annals.

Clinical factors for tumor response, progression, and survival in nivolumab for advanced renal cell carcinoma in the SNiP‐RCC study

M. Oya, M. Fujisawa, M. Shiota, 2023, International journal of urology : official journal of the Japanese Urological Association.

Scleroderma renal crisis in progressive systemic sclerosis: a case report.

S. Kagawa, K. Hashine, A. Imagawa, 1990, Hinyokika kiyo. Acta urologica Japonica.

Efficacy and safety of abiraterone acetate (AA) and low-dose prednisone (P) in Japanese patients with newly diagnosed, metastatic, hormone-naïve prostate cancer (mHNPC): Subgroup analysis of LATITUDE trial.

M. Oya, K. Fizazi, H. Kanayama, 2018 .

Phase II clinical trial of sorafenib plus interferon-alpha treatment for patients with metastatic renal cell carcinoma in Japan

T. Fujioka, K. Tatsugami, S. Naito, 2015, BMC Cancer.

Surveillance biopsy and active treatment during active surveillance for low-risk prostate cancer

K. Hashine, I. Ninomiya, H. Iio, 2013, International Journal of Clinical Oncology.

Reclassification prediction of first-year protocol biopsy on active surveillance of prostate cancer by p2PSA-related parameters: from PRIAS-JAPAN

O. Ogawa, H. Sasaki, A. Yokomizo, 2021, Prostate Cancer and Prostatic Diseases.

PRIMARY DIFFUSE LARGE CELL LYMPHOMA OF THE PENIS

Y. Sumiyoshi, K. Hashine, M. Akiyama, 1994, International journal of urology : official journal of the Japanese Urological Association.